Oral agents offer glycemic control, improved beta-cell function in severe hyperglycemia

11 May 2016


The combination DPP-IV inhibitor plus metformin Kombiglyze XR was as effective as glipizide XL in lowering blood glucose and improving beta-cell function in patients with newly diagnosed type-2 diabetes and severe hyperglycemia, according to recently published results in JCEM.

Healio


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story